Loading…

Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements

BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe u...

Full description

Saved in:
Bibliographic Details
Published in:Open heart 2024-12, Vol.11 (2), p.e002884
Main Authors: Chang, Rachel Si-Wen, Chiu, I-min, Tacon, Phillip, Abiragi, Michael, Cao, Louie, Hong, Gloria, Le, Jonathan, Zou, James, Daluwatte, Chathuri, Ricchiuto, Piero, Ouyang, David
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843
container_end_page
container_issue 2
container_start_page e002884
container_title Open heart
container_volume 11
creator Chang, Rachel Si-Wen
Chiu, I-min
Tacon, Phillip
Abiragi, Michael
Cao, Louie
Hong, Gloria
Le, Jonathan
Zou, James
Daluwatte, Chathuri
Ricchiuto, Piero
Ouyang, David
description BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.
doi_str_mv 10.1136/openhrt-2024-002884
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cc8304af7f82460db39ee3d2d07077c8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_cc8304af7f82460db39ee3d2d07077c8</doaj_id><sourcerecordid>3147673082</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843</originalsourceid><addsrcrecordid>eNpdkktv1DAUhS0EotXQX4CEIrFhE3r9iB2vECqvSpXYwNpy7JsZj5J4sBOk_vs6MwO0rGzde-7nY_sQ8prCe0q5vI4HnHZprhkwUQOwthXPyCWDhtdcMvH80f6CXOW8BwDKGglaviQXXEstGiUuif2EM7o5xKmKfeVs8sG6yo73Qww-5pCrJYdpW43W7cKE1YA2TWuhDKS4zGsN3S4eJ-M22cMuuGpEm5eEI05zfkVe9HbIeHVeN-Tnl88_br7Vd9-_3t58vKs7JqSom05S1Nox3XurAZUGKqGXjWRSMcVRd53DzjqHXradA-Be9Aot5xp9K_iG3J64Ptq9OaQw2nRvog3mWIhpa2yagxvQONdyELZXfVvOBt8VBHLPPChQqjQ35MOJdVi6Eb0r90h2eAJ92pnCzmzjb0OplErw1c27MyHFXwvm2YwhOxwGO2FcsuFUKFpMKF6kb_-T7uOSpvJWR5VUHFpWVG8eW_rr5c9XFsH1SdCN-38ECmbNiznnxax5Mae88AeRGbQx</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147673082</pqid></control><display><type>article</type><title>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</title><source>BMJ Open Access Journals</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Chang, Rachel Si-Wen ; Chiu, I-min ; Tacon, Phillip ; Abiragi, Michael ; Cao, Louie ; Hong, Gloria ; Le, Jonathan ; Zou, James ; Daluwatte, Chathuri ; Ricchiuto, Piero ; Ouyang, David</creator><creatorcontrib>Chang, Rachel Si-Wen ; Chiu, I-min ; Tacon, Phillip ; Abiragi, Michael ; Cao, Louie ; Hong, Gloria ; Le, Jonathan ; Zou, James ; Daluwatte, Chathuri ; Ricchiuto, Piero ; Ouyang, David</creatorcontrib><description>BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.</description><identifier>ISSN: 2053-3624</identifier><identifier>ISSN: 2398-595X</identifier><identifier>EISSN: 2053-3624</identifier><identifier>DOI: 10.1136/openhrt-2024-002884</identifier><identifier>PMID: 39694574</identifier><language>eng</language><publisher>England: British Cardiovascular Society</publisher><subject>Accuracy ; Aged ; Amyloidosis ; Amyloidosis - diagnosis ; Amyloidosis - diagnostic imaging ; Amyloidosis - physiopathology ; Artificial intelligence ; Cardiac arrhythmia ; Cardiomyopathies - diagnosis ; Cardiomyopathies - diagnostic imaging ; Cardiomyopathies - physiopathology ; Cardiomyopathy, Restrictive ; Cardiovascular disease ; Coronary vessels ; Deep learning ; Diabetes ; Diagnostic Imaging ; Echocardiography ; Echocardiography - methods ; Ejection fraction ; Feature selection ; Female ; Heart failure ; Heart Failure and Cardiomyopathies ; Humans ; Hypertension ; Machine Learning ; Male ; Middle Aged ; Original Research ; Patients ; Performance evaluation ; Predictive Value of Tests ; Pulmonary arteries ; Reproducibility of Results ; Retrospective Studies ; Statistical analysis ; Ultrasonic imaging ; Vein &amp; artery diseases</subject><ispartof>Open heart, 2024-12, Vol.11 (2), p.e002884</ispartof><rights>Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843</cites><orcidid>0000-0002-8969-2757</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3147673082/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3147673082?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,55350,75126,77660,77686</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39694574$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Rachel Si-Wen</creatorcontrib><creatorcontrib>Chiu, I-min</creatorcontrib><creatorcontrib>Tacon, Phillip</creatorcontrib><creatorcontrib>Abiragi, Michael</creatorcontrib><creatorcontrib>Cao, Louie</creatorcontrib><creatorcontrib>Hong, Gloria</creatorcontrib><creatorcontrib>Le, Jonathan</creatorcontrib><creatorcontrib>Zou, James</creatorcontrib><creatorcontrib>Daluwatte, Chathuri</creatorcontrib><creatorcontrib>Ricchiuto, Piero</creatorcontrib><creatorcontrib>Ouyang, David</creatorcontrib><title>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</title><title>Open heart</title><addtitle>Open Heart</addtitle><addtitle>Open Heart</addtitle><description>BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.</description><subject>Accuracy</subject><subject>Aged</subject><subject>Amyloidosis</subject><subject>Amyloidosis - diagnosis</subject><subject>Amyloidosis - diagnostic imaging</subject><subject>Amyloidosis - physiopathology</subject><subject>Artificial intelligence</subject><subject>Cardiac arrhythmia</subject><subject>Cardiomyopathies - diagnosis</subject><subject>Cardiomyopathies - diagnostic imaging</subject><subject>Cardiomyopathies - physiopathology</subject><subject>Cardiomyopathy, Restrictive</subject><subject>Cardiovascular disease</subject><subject>Coronary vessels</subject><subject>Deep learning</subject><subject>Diabetes</subject><subject>Diagnostic Imaging</subject><subject>Echocardiography</subject><subject>Echocardiography - methods</subject><subject>Ejection fraction</subject><subject>Feature selection</subject><subject>Female</subject><subject>Heart failure</subject><subject>Heart Failure and Cardiomyopathies</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Machine Learning</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original Research</subject><subject>Patients</subject><subject>Performance evaluation</subject><subject>Predictive Value of Tests</subject><subject>Pulmonary arteries</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Statistical analysis</subject><subject>Ultrasonic imaging</subject><subject>Vein &amp; artery diseases</subject><issn>2053-3624</issn><issn>2398-595X</issn><issn>2053-3624</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkktv1DAUhS0EotXQX4CEIrFhE3r9iB2vECqvSpXYwNpy7JsZj5J4sBOk_vs6MwO0rGzde-7nY_sQ8prCe0q5vI4HnHZprhkwUQOwthXPyCWDhtdcMvH80f6CXOW8BwDKGglaviQXXEstGiUuif2EM7o5xKmKfeVs8sG6yo73Qww-5pCrJYdpW43W7cKE1YA2TWuhDKS4zGsN3S4eJ-M22cMuuGpEm5eEI05zfkVe9HbIeHVeN-Tnl88_br7Vd9-_3t58vKs7JqSom05S1Nox3XurAZUGKqGXjWRSMcVRd53DzjqHXradA-Be9Aot5xp9K_iG3J64Ptq9OaQw2nRvog3mWIhpa2yagxvQONdyELZXfVvOBt8VBHLPPChQqjQ35MOJdVi6Eb0r90h2eAJ92pnCzmzjb0OplErw1c27MyHFXwvm2YwhOxwGO2FcsuFUKFpMKF6kb_-T7uOSpvJWR5VUHFpWVG8eW_rr5c9XFsH1SdCN-38ECmbNiznnxax5Mae88AeRGbQx</recordid><startdate>20241218</startdate><enddate>20241218</enddate><creator>Chang, Rachel Si-Wen</creator><creator>Chiu, I-min</creator><creator>Tacon, Phillip</creator><creator>Abiragi, Michael</creator><creator>Cao, Louie</creator><creator>Hong, Gloria</creator><creator>Le, Jonathan</creator><creator>Zou, James</creator><creator>Daluwatte, Chathuri</creator><creator>Ricchiuto, Piero</creator><creator>Ouyang, David</creator><general>British Cardiovascular Society</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8969-2757</orcidid></search><sort><creationdate>20241218</creationdate><title>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</title><author>Chang, Rachel Si-Wen ; Chiu, I-min ; Tacon, Phillip ; Abiragi, Michael ; Cao, Louie ; Hong, Gloria ; Le, Jonathan ; Zou, James ; Daluwatte, Chathuri ; Ricchiuto, Piero ; Ouyang, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accuracy</topic><topic>Aged</topic><topic>Amyloidosis</topic><topic>Amyloidosis - diagnosis</topic><topic>Amyloidosis - diagnostic imaging</topic><topic>Amyloidosis - physiopathology</topic><topic>Artificial intelligence</topic><topic>Cardiac arrhythmia</topic><topic>Cardiomyopathies - diagnosis</topic><topic>Cardiomyopathies - diagnostic imaging</topic><topic>Cardiomyopathies - physiopathology</topic><topic>Cardiomyopathy, Restrictive</topic><topic>Cardiovascular disease</topic><topic>Coronary vessels</topic><topic>Deep learning</topic><topic>Diabetes</topic><topic>Diagnostic Imaging</topic><topic>Echocardiography</topic><topic>Echocardiography - methods</topic><topic>Ejection fraction</topic><topic>Feature selection</topic><topic>Female</topic><topic>Heart failure</topic><topic>Heart Failure and Cardiomyopathies</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Machine Learning</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original Research</topic><topic>Patients</topic><topic>Performance evaluation</topic><topic>Predictive Value of Tests</topic><topic>Pulmonary arteries</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Statistical analysis</topic><topic>Ultrasonic imaging</topic><topic>Vein &amp; artery diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Rachel Si-Wen</creatorcontrib><creatorcontrib>Chiu, I-min</creatorcontrib><creatorcontrib>Tacon, Phillip</creatorcontrib><creatorcontrib>Abiragi, Michael</creatorcontrib><creatorcontrib>Cao, Louie</creatorcontrib><creatorcontrib>Hong, Gloria</creatorcontrib><creatorcontrib>Le, Jonathan</creatorcontrib><creatorcontrib>Zou, James</creatorcontrib><creatorcontrib>Daluwatte, Chathuri</creatorcontrib><creatorcontrib>Ricchiuto, Piero</creatorcontrib><creatorcontrib>Ouyang, David</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Open heart</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Rachel Si-Wen</au><au>Chiu, I-min</au><au>Tacon, Phillip</au><au>Abiragi, Michael</au><au>Cao, Louie</au><au>Hong, Gloria</au><au>Le, Jonathan</au><au>Zou, James</au><au>Daluwatte, Chathuri</au><au>Ricchiuto, Piero</au><au>Ouyang, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</atitle><jtitle>Open heart</jtitle><stitle>Open Heart</stitle><addtitle>Open Heart</addtitle><date>2024-12-18</date><risdate>2024</risdate><volume>11</volume><issue>2</issue><spage>e002884</spage><pages>e002884-</pages><issn>2053-3624</issn><issn>2398-595X</issn><eissn>2053-3624</eissn><abstract>BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.</abstract><cop>England</cop><pub>British Cardiovascular Society</pub><pmid>39694574</pmid><doi>10.1136/openhrt-2024-002884</doi><orcidid>https://orcid.org/0000-0002-8969-2757</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2053-3624
ispartof Open heart, 2024-12, Vol.11 (2), p.e002884
issn 2053-3624
2398-595X
2053-3624
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_cc8304af7f82460db39ee3d2d07077c8
source BMJ Open Access Journals; Publicly Available Content Database; PubMed Central
subjects Accuracy
Aged
Amyloidosis
Amyloidosis - diagnosis
Amyloidosis - diagnostic imaging
Amyloidosis - physiopathology
Artificial intelligence
Cardiac arrhythmia
Cardiomyopathies - diagnosis
Cardiomyopathies - diagnostic imaging
Cardiomyopathies - physiopathology
Cardiomyopathy, Restrictive
Cardiovascular disease
Coronary vessels
Deep learning
Diabetes
Diagnostic Imaging
Echocardiography
Echocardiography - methods
Ejection fraction
Feature selection
Female
Heart failure
Heart Failure and Cardiomyopathies
Humans
Hypertension
Machine Learning
Male
Middle Aged
Original Research
Patients
Performance evaluation
Predictive Value of Tests
Pulmonary arteries
Reproducibility of Results
Retrospective Studies
Statistical analysis
Ultrasonic imaging
Vein & artery diseases
title Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A12%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20cardiac%20amyloidosis%20using%20machine%20learning%20on%20routine%20echocardiographic%20measurements&rft.jtitle=Open%20heart&rft.au=Chang,%20Rachel%20Si-Wen&rft.date=2024-12-18&rft.volume=11&rft.issue=2&rft.spage=e002884&rft.pages=e002884-&rft.issn=2053-3624&rft.eissn=2053-3624&rft_id=info:doi/10.1136/openhrt-2024-002884&rft_dat=%3Cproquest_doaj_%3E3147673082%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3147673082&rft_id=info:pmid/39694574&rfr_iscdi=true